The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|January 5, 2023
Terminally Ill Cancer Patient Cited for Cannabis Use in Hospital
Author(s)Erin McEvoy
In December 2022, hospital staff in Hays, Kansas reported a terminally ill cancer patient to police for use of a cannabis vape pen.
Advertisement
In late December 2022, police officers issued a citation for a drug violation to 69-year-old Greg Bretz and removed his vaping pen and tetrahydrocannabinol (THC) paste, which had been confiscated by hospital staff (1). Bretz had been using the cannabis products in the hospital to cope with the symptoms of his terminal, inoperable cancer. The drug possession ticket was later dismissed.
“You’d think they would have shown a lot more compassion and not done anything,” said Lee Bretz, Greg Bretz’s son (2). “He can’t make it to court. He’s bedridden. He can’t move his legs.”
A local television station in Kansas reported that the news of the situation, which had gone viral online, purportedly led to alleged threats against the hospital and police (2).
“As a police officer, we don’t determine what the law is,” said Hays police chief Don Scheibler (2). “I think the discussion about medical marijuana needs to happen.”
“It is traumatic enough to be dying of cancer – it is absolutely unconscionable to add on, for no reason beyond fealty to a losing drug war, the added trauma of being arrested,” said Dr. Peter Grinspoon, a cannabis specialist (1). “While cannabis hasn’t yet been shown to ‘cure’ cancer in humans, it is spectacularly effective for the ravages of chemotherapy – the nausea, vomiting and lack of appetite – as well as the pain, anxiety and insomnia that almost always accompany the experience of a terminal cancer.”
Though Kansas does have a medical cannabis program, medical cannabis advocacy is still needed across the country, according to Americans for Safe Access (ASA), the nation’s largest nonprofit that represents medical cannabis patients, doctors, and researchers. “On paper, it looks like medical cannabis policy is doing well,” said ASA’s founder and president Steph Sherer in a recent blog (3). “But on the ground, we see medical cannabis programs corroding alongside adult-use programs, fewer bills passing to improve state medical cannabis programs, millions of people still left without access, and a lack of movement for federal protections.”
References
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement